These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9920128)

  • 1. Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Dekitsch C; Schein R; Markopulos E; Kuen B; Graninger W; Georgopoulos A
    J Med Microbiol; 1999 Jan; 48(1):73-77. PubMed ID: 9920128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
    J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins.
    Brisse S; Milatovic D; Fluit AC; Verhoef J; Martin N; Scheuring S; Köhrer K; Schmitz FJ
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2051-5. PubMed ID: 10428935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin.
    Stewart BA; Johnson AP; Woodford N
    J Med Microbiol; 1999 Dec; 48(12):1103-1106. PubMed ID: 10591164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
    Brown JC; Shanahan PM; Jesudason MV; Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1996 May; 37(5):891-900. PubMed ID: 8737139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.
    Lascols C; Robert J; Cattoir V; Bébéar C; Cavallo JD; Podglajen I; Ploy MC; Bonnet R; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):402-9. PubMed ID: 17254753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR.
    Rahman M; Mauff G; Levy J; Couturier M; Pulverer G; Glasdorff N; Butzler JP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2488-91. PubMed ID: 7840594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
    Oh H; El Amin N; Davies T; Appelbaum PC; Edlund C
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.
    Charvalos E; Peteinaki E; Spyridaki I; Manetas S; Tselentis Y
    J Clin Lab Anal; 1996; 10(3):129-33. PubMed ID: 8731499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Kawamura T; Takahashi Y; Okezaki E; Nagata O; Kato H; Kawada Y
    J Antimicrob Chemother; 1997 Dec; 40(6):907-9. PubMed ID: 9462448
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.
    Ruiz J; Marco F; Goñi P; Gallardo F; Mensa J; Trilla A; Jimenez de Anta T; Vila J
    J Antimicrob Chemother; 1995 Oct; 36(4):737-8. PubMed ID: 8591951
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased quinolone susceptibility in high percentage of Enterobacter cloacae clinical isolates caused only by Qnr determinants.
    Zhao X; Xu X; Zhu D; Ye X; Wang M
    Diagn Microbiol Infect Dis; 2010 May; 67(1):110-3. PubMed ID: 20227223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotyping of quinolone-resistant Neisseria gonorrhoeae isolates with alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Maeda SI; Saito I; Kawada Y
    J Antimicrob Chemother; 1998 Mar; 41(3):418-20. PubMed ID: 9578173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.